Literature DB >> 24440705

MicroRNA-490-3p inhibits proliferation of A549 lung cancer cells by targeting CCND1.

Haihua Gu1, Tao Yang1, Shaozi Fu1, Xiaofan Chen1, Lei Guo1, Yiming Ni2.   

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs that negatively regulate the translation of messenger RNAs by binding their 3'-untranslated region (3'UTR). In this study, we found that miR-490-3p is significantly down-regulated in A549 lung cancer cells compared with the normal bronchial epithelial cell line. To better characterize the role of miR-490-3p in A549 cells, we performed a gain-of-function analysis by transfecting the A549 cells with chemically synthesized miR-490-3P mimics. Overexpression of miR-490-3P evidently inhibits cell proliferation via G1-phase arrest. We also found that forced expression of miR-490-3P decreased both mRNA and protein levels of CCND1, which plays a key role in G1/S phase transition. In addition, the dual-luciferase reporter assays indicated that miR-490-3P directly targets CCND1 through binding its 3'UTR. These findings indicated miR-490-3P could be a potential suppressor of cellular proliferation.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CCND1; Proliferation; miR-490-3p

Mesh:

Substances:

Year:  2014        PMID: 24440705     DOI: 10.1016/j.bbrc.2014.01.020

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  26 in total

1.  miR-342-3p targets RAP2B to suppress proliferation and invasion of non-small cell lung cancer cells.

Authors:  Xiao Xie; Hongtao Liu; Mingsong Wang; Fangbao Ding; Haibo Xiao; Fengqing Hu; Rui Hu; Ju Mei
Journal:  Tumour Biol       Date:  2015-02-09

2.  Potential targets and clinical value of miR-490-5p in hepatocellular carcinoma: a study based on TCGA, qRT-PCR and bioinformatics analyses.

Authors:  Hong Yang; Lu Zhang; Xiao-Dong Wang; Meng-Lan Huang; Peng Lin; Yu-Yan Pang; Zhen-Bo Feng; Gang Chen
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

3.  MicroRNA-543 acts as an oncogene by targeting PAQR3 in hepatocellular carcinoma.

Authors:  Lei Yu; Luting Zhou; Yu Cheng; Lei Sun; Jian Fan; Jinlong Liang; Mujie Guo; Ning Liu; Liying Zhu
Journal:  Am J Cancer Res       Date:  2014-11-19       Impact factor: 6.166

4.  TR4 nuclear receptor promotes clear cell renal cell carcinoma (ccRCC) vasculogenic mimicry (VM) formation and metastasis via altering the miR490-3p/vimentin signals.

Authors:  Jian Bai; Shuyuan Yeh; Xiaofu Qiu; Linyi Hu; Jun Zeng; Yangke Cai; Li Zuo; Gonghui Li; Guosheng Yang; Chawnshang Chang
Journal:  Oncogene       Date:  2018-07-04       Impact factor: 9.867

5.  The diagnostic and prognostic value of plasma microRNA-125b-5p in patients with multiple myeloma.

Authors:  Yanxia Jiang; Yajing Luan; Hong Chang; Guoan Chen
Journal:  Oncol Lett       Date:  2018-07-11       Impact factor: 2.967

6.  Regulation of cyclin D1 by arsenic and microRNA inhibits adipogenesis.

Authors:  Kevin Beezhold; Linda R Klei; Aaron Barchowsky
Journal:  Toxicol Lett       Date:  2016-12-05       Impact factor: 4.372

7.  LncARSR promotes non-small-cell lung cancer progression via regulating PTEN/Akt.

Authors:  Jie Ying; Jian Yang; Yingzi Liu
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060

8.  MicroRNA expression profiles and target prediction in neonatal Wistar rat lungs during the development of bronchopulmonary dysplasia.

Authors:  Yujiao Xing; Jianhua Fu; Haiping Yang; Li Yao; Lin Qiao; Yanna Du; Xindong Xue
Journal:  Int J Mol Med       Date:  2015-09-17       Impact factor: 4.101

Review 9.  MicroRNAs are critical regulators of senescence and aging in mesenchymal stem cells.

Authors:  Matthew L Potter; William D Hill; Carlos M Isales; Mark W Hamrick; Sadanand Fulzele
Journal:  Bone       Date:  2020-10-03       Impact factor: 4.398

Review 10.  MicroRNA-490-3p and -490-5p in carcinogenesis: Separate or the same goal?

Authors:  Yin Li; Dongmei Tian; Hao Chen; Yuanting Cai; Sang Chen; Shiwei Duan
Journal:  Oncol Lett       Date:  2021-07-22       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.